— Why it moved
Why PMI Stock More Than Doubled Today — June 2, 2026
SynCardia's parent said its next-gen Emperor artificial heart passed preclinical implant studies, and 826 million shares chased a 17-cent stock that had already lost 99% from its high.
What moved it
Picard Medical, parent of artificial-heart maker SynCardia, announced successful next-generation preclinical implant studies for its Emperor Total Artificial Heart. Genuine news, but preclinical is the operative word.
The mechanics
PMI came into the day at $0.17, almost 99% below its 52-week high. A stock that broken with a 26M float doesn't need much of a push. The headline pulled in 826M shares of volume, so the float turned over more than 30 times in one session.
Numbers
- Cap: ~$14M / float: 26.2M
- Day volume: 826M (48x average)
- Prev close: $0.1684, already up ~110% premarket when the alert fired
- 52w range: $0.11–$13.68
Where it ended up
The Stock Pulse alert came at 7:25 AM at $0.356. The stock ground higher for almost two hours and topped at $0.4131 at 9:14 AM, +16% from the alert. Sellers took over right after the bell. It closed at $0.2746, 23% under the alert price.
Reality check
- Peak to close was a 34% drawdown. The premarket buyers who held all day round-tripped.
- Preclinical implants are years from approval, and this is a company doing about $1M a quarter in revenue.
- Post-mortem, not a pitch.